Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis - Wikidata - awgldk - TriplyDB

Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis

Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis

http://www.wikidata.org/entity/Q35034689

about

Human genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis Regulation of Collagen V Expression and Epithelial-Mesenchymal Transition by miR-185 and miR-186 during Idiopathic Pulmonary Fibrosis.Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis The future of the development of medicines in idiopathic pulmonary fibrosis.Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.SMAD3 expression and regulation of fibroplasia in vocal fold injury.Novel Drug Targets For Idiopathic Pulmonary Fibrosis.Idiopathic pulmonary fibrosis and a role for autoimmunity.Type V Collagen in Health, Disease, and Fibrosis.Basement membranes and autoimmune diseases.New treatment directions for IPF: current status of ongoing and upcoming clinical trials.Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis.Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis.MUC5B promoter polymorphisms and risk of coal workers' pneumoconiosis in a Chinese population.Autoimmune Reactivity in Graft Injury: Player or Bystander?Investigational drugs for idiopathic pulmonary fibrosis.Mesenchymal stem cells in idiopathic pulmonary fibrosis.Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.Idiopathic Pulmonary Fibrosis (IPF): An Overview

P2860

Q28085065-55D787AB-88A4-44CC-9A73-F2EFB08031BB Q30276395-3E8CFDEB-4F21-4547-BE50-F12E165EB462 Q33714064-2F29F006-1B0E-42A1-B6CB-1411DC75D651 Q33901646-CC8B197F-A774-4806-AA81-220B7C898EEC Q34365488-DDA71D2D-0AFA-47BB-96E8-D26B394130E9 Q35666076-5A05E297-79FD-4ADA-9F0A-BEB8EF4E4B8F Q35785682-E1050BC2-14FC-414A-A605-C23512142FF3 Q36913772-89F626C8-3528-49A5-9083-7F8B0A70225B Q38702309-3232A72C-5CF8-4207-86F2-0A0AA511D92E Q38725808-77D23EB3-3301-471E-9C94-BECCCB5FD7B6 Q38737879-24717083-60D6-472A-A73D-C3D5EC0F6782 Q38748579-6A260525-2944-4B10-AEA0-8B1DA48058E8 Q38920115-6D8F6FC7-03ED-4420-8CCF-6851453EF71B Q39330304-58E9064F-DB06-41B7-9F58-B659328E4DA3 Q39351661-0E806F2E-3F37-4C42-89AC-5FA340C0E20C Q40272697-AD432F7F-0D0E-42E5-84AC-65369DA745BE Q42479603-DCC32F8A-91FF-4991-92AE-43B0AA55AF8A Q44615266-8EDA5D18-B3F8-4148-8DA1-4B20D77A3B8E Q45763669-F6C1D067-8246-48F6-91CE-3700E076D17C Q46325791-E083A2D5-25EA-40C8-93A0-49D37617DACD Q47123592-4F79A709-2813-4132-8E8D-8BBEEF47816B Q47901631-74535F4F-A2A3-4B74-B2AF-531477B32566 Q47933314-61237D06-1C49-4559-AAC9-E866F5358625 Q47937434-FB7C01D3-C8A4-4F70-8A34-5F3DB1204414 Q48166486-C1DC6F8F-C9BE-4AFE-83C9-9939319F20E9 Q57170607-B3CF60E0-A398-42D0-86C0-1892C8E9ECCC

P2860

Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis

http://www.wikidata.org/entity/Q35034689

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Type V collagen induced tolera ...... nscripts in pulmonary fibrosis

@ast

Type V collagen induced tolera ...... nscripts in pulmonary fibrosis

@en

type

label

Type V collagen induced tolera ...... nscripts in pulmonary fibrosis

@ast

Type V collagen induced tolera ...... nscripts in pulmonary fibrosis

@en

prefLabel

Type V collagen induced tolera ...... nscripts in pulmonary fibrosis

@ast

Type V collagen induced tolera ...... nscripts in pulmonary fibrosis

@en

P1433

Q35034689-2FA5DEA3-0BB1-4435-AA44-A1E4653C4BFE

P1476

Q35034689-53D69E4A-0EA3-4B06-910C-4A3D725EAE86

P2093

Q35034689-16C93673-BDE8-4AB0-B746-1A5FAB0CE253

Q35034689-2A175416-77EE-40C4-AE1E-F7478B1E4FB4

Q35034689-34A6202F-C993-4882-92CD-1FCCC60BD60F

Q35034689-453F5A35-2BCD-4FD3-B420-19CFE48BA545

Q35034689-48F3B739-7BC9-4A9C-9B24-A717F0244574

Q35034689-5918B84A-CB2F-41E7-B62F-35324623D80E

Q35034689-73F369F3-40AA-41A6-A453-F32B8FA55BDA

Q35034689-7E3A180E-5B64-4CF2-BEB2-75789BB7A4C9

Q35034689-87059554-3B37-402F-A4E2-0AFB911F0052

Q35034689-8B700F87-8F53-462C-83DB-55550BF2E56A

P2860

Q35034689-0223A583-A205-4602-A7A3-F5B0C5D62AD8

Q35034689-034A440D-E4C4-461A-A6A5-B4AA7FFD462F

Q35034689-03AB1356-785A-443D-A3CA-30DC078A12C6

Q35034689-049F1028-1C6B-4A28-8445-8752B00516E7

Q35034689-061E62DA-6E9D-42A4-9669-D71CABBFFE23

Q35034689-07534924-FB94-47A1-908E-F3ED6CF26CA6

Q35034689-0BCDD500-6E1A-4A9F-A633-FAA65C68585A

Q35034689-1782F345-8837-409A-B322-32EDC63B8B8A

Q35034689-1CDEA4D9-EB4C-4D54-9671-43D66F867896

Q35034689-22731BE8-8261-4EAD-A44E-6D3E2C5C389D

P304

Q35034689-053B6285-8D62-41D0-9DA9-2BAAE9CA7622

P31

Q35034689-8CB7D055-B70B-44D0-A244-63D380410DF1

P356

Q35034689-C633862C-9EDB-49FF-880D-C95618FF00A6

P407

Q35034689-B65867D2-279B-410D-A39E-FA0132D83711

P433

Q35034689-CB39CADE-4113-4C72-85F3-3F3722142086

P478

Q35034689-62948BA0-7B77-4E8C-833D-DF77A5144F98

P577

Q35034689-920B841E-F92D-4786-8BC8-2DEDB053F093

P5875

Q35034689-56351CE8-7392-45CA-9B0A-E4BBAA8AE27A

P698

Q35034689-E4AA5A0D-4094-46C0-8416-3D49648C7ECD

P921

Q35034689-FB86BB08-0E4A-4157-81AE-26A81EC9F5FC

P932

Q35034689-BFEC891F-D890-4C92-BFF5-ADEC3FCDFBB7

P356

JOURNAL.PONE.0076451

P1433

P1476

Type V collagen induced tolera ...... nscripts in pulmonary fibrosis

@en

P2093

Amanda J Fisher

http://www.w3.org/2001/XMLSchema#string

Amir Emtiazdjoo

http://www.w3.org/2001/XMLSchema#string

Chen Zhang

http://www.w3.org/2001/XMLSchema#string

David S Wilkes

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Mickler

http://www.w3.org/2001/XMLSchema#string

George E Sandusky

http://www.w3.org/2001/XMLSchema#string

Gerald N Smith

http://www.w3.org/2001/XMLSchema#string

Hongmei Gu

http://www.w3.org/2001/XMLSchema#string

Jeremy M Lott

http://www.w3.org/2001/XMLSchema#string

Katia Rothhaar

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction

Integrins: versatility, modulation, and signaling in cell adhesion

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

Pulmonary fibrosis: pathogenesis, etiology and regulation

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

The role of CXC chemokines in pulmonary fibrosis.

Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection

Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis.

FIZZ2/RELM-β induction and role in pulmonary fibrosis

Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.

P304

e76451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0076451

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258350830

http://www.w3.org/2001/XMLSchema#string

P698

24204629

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

3804565

http://www.w3.org/2001/XMLSchema#string